Ex Parte Campbell et al - Page 5


             Appeal No. 2006-2817                                                           Page 5               
             Application No. 10/734,979                                                                          

             including tricarbamoyl triazines which are disclosed in the Jacobs2 patent.  Id., ¶¶ 41             
             and 48.  The Examiner states that “Jacobs anticipates, in examples 4 and 5,                         
             compounds within the subgroup as claimed in claim 1.”  Answer, page 7.  The Examiner                
             acknowledges that Sadvary does not teach the remaining steps of claim 1.  Id., page 4.              
                   The Examiner relies on the specification for its teaching that it is conventional in          
             the art to apply coatings to automobiles by spraying the compositions, such as the                  
             composition described by Sadvary, on to the substrate surface in a spray booth, and                 
             then to discharge the overspray as wastewater “directly or indirectly” into the sewage              
             system.  Id., pages 4-5 (citing specification, ¶ 3 and 8).  The Examiner concludes that             
             “using a sewage treatment plant … at least a portion of [the] compound of formula I                 
             [would be removed] from the wastewater.”  Id., page 5.  These steps correspond to                   
             steps (b)-(e) of claim 1.                                                                           
                   Appellants state that the claimed Formula I compounds are advantageous                        
             because they can be removed from wastewater collected after the coating process,                    
             permitting them to be safely discharged into the sewage system.”  Brief, page 2.  They              
             urge that Sadvary does not suggest the claimed invention because he does not provide                
             direction on how to select those curing agents that would avoid aquatic toxicity, the               
             problem associated with the only commercially available triisocyanate triazine.  Brief,             
             pages 4-5.                                                                                          
                   In addressing whether the claimed subject matter would be obvious, we focus                   
             our review on step (a) of claim 1, particularly the obviousness of utilizing the compounds          
                                                                                                                 
             2 Jacobs et al. (Jacobs), U.S. Pat. No. 5,084,541, issued Jan. 28, 1992, which is incorporated by   
             reference.  Specification, ¶ 48.  The Examiner also referred to U.S. Pat. No 4,939,213, which is a  
             divisional of U.S. Pat. No. 5,084,541.                                                              





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007